Transient perturbation of endothelial integrity induced by natural antibodies and complement
about
Kidney xenotransplantationComplement and its role in protection and pathogenesis of flavivirus infectionsDisordered regulation of coagulation and platelet activation in xenotransplantation.Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndromeSTEC-HUS, atypical HUS and TTP are all diseases of complement activation.Factors in xenograft rejection.Role of complement in xenotransplantation.Current status of xenotransplantation.Xenotransplantation--2000Xenotransplantation and other means of organ replacement.The immunological hurdles to cardiac xenotransplantation.Fate of antigen in xenotransplantation: implications for acute vascular rejection and accommodation.Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.B cells in cardiac transplants: from clinical questions to experimental modelsComplement-mediated regulation of tissue factor activity in endothelium.Endothelial cell protection in xenotransplantation: looking after a key player in rejection.Human leukocyte antigen antibody incompatible renal transplantationIdentification of the tetraspanin CD82 as a new barrier to xenotransplantation.The spectrum of antibody-mediated renal allograft injury: implications for treatment.Accommodation in organ transplantation.Biochemical and functional characterization of xenoreactive natural antibodies in hu-PBL-SCID mice.The role of antibodies in transplantation.Modulation of eicosanoid metabolism in endothelial cells in a xenograft model. Role of cyclooxygenase-2.Developmental changes in circulating IL-8/CXCL8 isoforms in neonates.Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection.Interleukin-4 induces up-regulation of endothelial cell claudin-5 through activation of FoxO1: role in protection from complement-mediated injury.Transgenic pigs designed to express human CD59 and H-transferase to avoid humoral xenograft rejection.Establishment of an immortalized PARP-1-/- murine endothelial cell line: a new tool to study PARP-1 mediated endothelial cell dysfunction.Clinical immunology.TH1 and TH2 lymphocytes in autoimmunity.Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling.Constitutive repression of interleukin-1alpha in endothelial cells.Thromboxane mediates pulmonary hypertension and lung inflammation during hyperacute lung rejection.Activation of porcine endothelium in response to xenogeneic serum causes thrombosis independently of platelet activation.Different approaches to heart valve decellularization: A comprehensive overview of the past 30 years.Inhalation anesthesia of rats: influence of the fraction of inspired oxygen on limb ischemia/reperfusion injury.Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model.Anti-DNA IgA autoantibodies are spontaneously generated in mouse Peyer's patches.The membrane attack complex of complement contributes to plasmin-induced synthesis of platelet-activating factor by endothelial cells and neutrophilsStrategies for preventing porcine xenograft rejection: recent progress and future developments
P2860
Q26822638-68D23741-80FD-4B77-9392-0EADC860DFFDQ27490236-9D82D7D7-3602-4BDC-B48A-434B82425D4FQ33334538-4EEDD003-F1A4-41B4-A5D4-C88E63E5B27DQ33396792-688FE469-D35D-4BCA-B645-EEB5642AD3A1Q33403359-7EC62F5E-F855-4188-82F8-3E1FB297D40BQ33692579-896E444A-4DC8-4A4D-86E1-9C0E9D71139BQ33811443-2C4C43E1-B837-42E6-8772-3378A887B06EQ33811452-2C34DA5E-4A39-452A-9D32-9DA13BFB7FC0Q33893048-7554BF41-9614-435A-BCFB-94DD7B818EF0Q34572172-0D8F9160-75EF-4983-92AB-3C48E1B93525Q34582619-3856E6C7-4166-4696-98DB-ADDE6E357560Q35765045-67C4EA99-7F2E-4846-81F8-B6C91209A0E8Q35766497-05BE9AFB-E09A-4E28-B4C1-9597CFFD8DFAQ35840324-367C91CA-0BB4-4F8C-A96C-C346E39B6B0CQ36365648-1CADDF14-9075-4D18-BBF2-17C5DDB795EEQ36404498-DC59A0E9-D8D2-4BC3-8DB6-AD78EE89E7EFQ36612789-1A33242B-2605-4F9E-9ECD-154C2CADE088Q37107520-0F2C1F96-0F4C-4DC1-977D-D6560C3D4F76Q37176570-A4DD56C7-5182-457E-9620-2FBB7C6F4B8CQ37236857-9BC226EA-9B6B-4D6B-A007-C2866DCBEE64Q37352623-C09CF2B5-F964-45AA-B560-AA2723985970Q37363951-E4ACE359-E4A4-4556-948F-347D1C82B93FQ37371806-FF82CAF5-0342-4251-B872-E272B4D86348Q37375589-A3FD50CB-B81F-4036-B1F6-4A533A7ED7F6Q37441972-95A03948-5664-4029-B2D7-3B62EC37BF87Q37459317-927FE051-111F-4706-8533-908B7530E9A4Q38289368-A109109F-3C76-4580-AD8B-2CACB3CAB899Q40461084-CAD5A2DD-3ED1-4866-AB3D-61A51E1F5026Q41005450-94EB9DD8-0177-4A21-87A6-0C83610D3708Q41039934-F4D9279F-559B-42CD-9E83-D1556D1AA366Q41837398-D1BBC277-6D79-4FEE-8CE9-64B045385A2BQ41911660-9378FB2A-57D2-41F6-B9D3-275431B05D9CQ43610748-1BA1C9B7-F9E2-481D-B126-E9FFB8DB916CQ45252432-A1441B4B-BCB1-422F-8E66-CFBB6FD3A872Q47422814-9CCD7055-6446-48FA-A0F0-AA61439B98DEQ47655736-D0C9F84F-9E6A-4DDF-A59C-4B608B155DB5Q47712226-DDC08E23-A32A-4B5B-BE9C-D75437FF850CQ48006816-67C70706-0233-47B2-BEBC-E0F3899D8ADEQ58831646-D6DCFCCE-1D62-4B50-B54B-ED0A4539EF04Q58836924-487DE3CC-C6D9-4C01-919F-9C00B9FEFA2D
P2860
Transient perturbation of endothelial integrity induced by natural antibodies and complement
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Transient perturbation of endo ...... ural antibodies and complement
@ast
Transient perturbation of endo ...... ural antibodies and complement
@en
type
label
Transient perturbation of endo ...... ural antibodies and complement
@ast
Transient perturbation of endo ...... ural antibodies and complement
@en
prefLabel
Transient perturbation of endo ...... ural antibodies and complement
@ast
Transient perturbation of endo ...... ural antibodies and complement
@en
P2860
P356
P1476
Transient perturbation of endo ...... ural antibodies and complement
@en
P2093
P2860
P356
10.1084/JEM.181.1.21
P407
P577
1995-01-01T00:00:00Z